BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24461303)

  • 21. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchioloalveolar carcinoma: the case for two diseases.
    Garfield DH; Cadranel J; West HL
    Clin Lung Cancer; 2008 Jan; 9(1):24-9. PubMed ID: 18282354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK-rearranged adenocarcinoma with extensive mucin production can mimic mucinous adenocarcinoma: clinicopathological analysis and comprehensive histological comparison with KRAS-mutated mucinous adenocarcinoma.
    Cha YJ; Han J; Hwang SH; Lee TB; Kim H; Zo JI
    Pathology; 2016 Jun; 48(4):325-9. PubMed ID: 27114375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
    Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
    Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
    Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
    Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between EGFR mutations and clinicopathological features of lung adenocarcinomas diagnosed via small biopsies.
    Kim HJ; Choi EY; Jin HJ; Shin KC
    Anticancer Res; 2014 Jun; 34(6):3189-95. PubMed ID: 24922693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
    Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
    Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
    Garfield DH; Cadranel JL; Wislez M; Franklin WA; Hirsch FR
    J Thorac Oncol; 2006 May; 1(4):344-59. PubMed ID: 17409882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytological markers for predicting ALK-positive pulmonary adenocarcinoma.
    Miyata K; Morita S; Dejima H; Seki N; Matsutani N; Mieno M; Kondo F; Soejima Y; Tanaka F; Sawabe M
    Diagn Cytopathol; 2017 Nov; 45(11):963-970. PubMed ID: 28834601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G
    Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
    Erman M; Grunenwald D; Penault-Llorca F; Grenier J; Besse B; Validire P; Morat L; Girard P; Le Chevalier T; Sabatier L; Soria JC
    Lung Cancer; 2005 Mar; 47(3):315-23. PubMed ID: 15713515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma.
    Carretta A; Canneto B; Calori G; Ceresoli GL; Campagnoli E; Arrigoni G; Vagani A; Zannini P
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):367-71. PubMed ID: 11463559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
    Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
    Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchioloalveolar carcinoma: clinical, radiographic, and pathological findings. Surgical results.
    Volpino P; D'Andrea N; Cangemi R; Mingazzini P; Cangemi B; Cangemi V
    J Cardiovasc Surg (Torino); 2001 Apr; 42(2):261-7. PubMed ID: 11398743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
    Okayama H; Kohno T; Ishii Y; Shimada Y; Shiraishi K; Iwakawa R; Furuta K; Tsuta K; Shibata T; Yamamoto S; Watanabe S; Sakamoto H; Kumamoto K; Takenoshita S; Gotoh N; Mizuno H; Sarai A; Kawano S; Yamaguchi R; Miyano S; Yokota J
    Cancer Res; 2012 Jan; 72(1):100-11. PubMed ID: 22080568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma.
    Yamakawa H; Takayanagi N; Ishiguro T; Kagiyama N; Shimizu Y; Sugita Y
    Intern Med; 2013; 52(24):2781-4. PubMed ID: 24334585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advanced Pneumonic-type Lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
    Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.